Clinical Trials Logo

Gastrointestinal Tumors clinical trials

View clinical trials related to Gastrointestinal Tumors.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04171141 Terminated - Clinical trials for Gastrointestinal Tumors

Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.

Start date: November 19, 2019
Phase: Phase 1
Study type: Interventional

A phase 1, open-label, dose escalation and expansion study of PF-07062119 in patients with selected advanced or metastatic gastrointestinal tumors

NCT ID: NCT01648465 Terminated - Clinical trials for Pancreatic Neuroendocrine Tumors

Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors

Start date: August 6, 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to explore the efficacy and safety of everolimus administered as a first-line treatment in newly-diagnosed patients with advanced or inoperable Gastrointestinal (GI) or pancreatic neuroendocrine tumors.